Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser zaps painful lumps in early HS trial

NCT ID NCT07155239

Symptom relief Sponsor: Wynn Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study tests a 1726-nm laser (AviClear) to reduce painful lumps and abscesses in hidradenitis suppurativa (HS), a chronic skin condition. Thirty adults with mild-to-moderate HS will have one side of their body treated with the laser and the other side with a sham procedure. The goal is to see if the laser safely lowers inflammation and improves symptoms over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
1726-nm diode laser (AviClear)
What this could lead to
If it works, this could point toward a non-invasive laser treatment to ease painful skin lumps in early-stage hidradenitis suppurativa.
What could go wrong
This is a very early Phase 1 pilot trial with only 30 people. The laser may not reduce symptoms better than no treatment, and results may not apply to all skin types or disease stages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults 18-60 years; any sex; Fitzpatrick I-VI. * Clinical HS, Hurley I-II (Investigator confirmed). * At least one inflammatory nodule in a paired, bilateral region (axilla, groin/inguinal, inframammary, inner thigh, or buttock) within 4 weeks prior to baseline. * Able to read/speak English/Chinese/Spanish/Vietnamese and sign consent. * Willing/able to comply with visits, pre/post-care, standardized photography. * Agree to avoid new HS procedures/therapies in study areas through Week 24. * No laser contraindication; agrees to shave/clip hair before treatments. * Optional translational cohort: willing to undergo 4-mm punch biopsy at baseline and Week 16 from the randomized regions (separate consent). Exclusion Criteria: * Hurley III (extensive sinus tracts). * No qualifying nodule(s) in paired bilateral regions in past 4 weeks. * Prior device/procedure to target areas within 3 months (chemical peel, dermabrasion, microneedling/RF, other lasers/LBB, cryo/chemo-destruction) * Had Botulinum toxin in target areas within 3 months or planned during study. * Had systemic retinoid (e.g., isotretinoin) within 3 months. * Photosensitizing meds that, in PI's judgment, materially increase risk and cannot be held. * Pregnancy/breastfeeding/plans to conceive during study. * Active infection, still healing wounds (investigator judgment) in target areas. * History of keloids/hypertrophic scars, radiation to target areas, malignancy in target areas, diagnosed immunodeficiency, uncontrolled coagulation disorder or therapeutic anticoagulation that cannot be safely managed. * Excessive tanning or inability to avoid tanning. * Any condition (medical/mental) or prisoner status that in PI's opinion compromises safety or adherence.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hidradenitis suppurativa (HS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hidradenitis suppurativa (HS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wynn Medical Center Rheumatology/Dermatology

    RECRUITING

    Rosemead, California, 91770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.